Diclofenac sodium salt, cyclo-oxygenase inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Diclofenac sodium salt, cyclo-oxygenase inhibitor (AB120621)
ab96732 staining Prostaglandin dehydrogenase 1 in MCF7 cells treated with diclofenac sodium salt (ab120621), by ICC/IF. Increase in Prostaglandin dehydrogenase 1 expression correlates with increased concentration of diclofenac sodium salt as described in literature.
The cells were incubated at 37°C for 6h in media containing different concentrations of ab120621 (diclofenac sodium salt) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab96732 (1 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody.
- Chemical Structure
Lab
Chemical Structure - Diclofenac sodium salt, cyclo-oxygenase inhibitor (AB120621)
2D chemical structure image of ab120621, Diclofenac sodium salt, cyclo-oxygenase inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Biochemical pharmacology 154:318-334 PubMed29800556
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com